Tecnología e Información para la Salud

What Tecnología e Información para la Salud does

Tecnología e Información para la Salud (TIS) is a privately held Mexico City-based healthcare consulting firm founded around 2009-2010, specializing in health economics, pharmacoeconomics, health technology assessment, and real-world evidence (RWE) generation. The company serves pharmaceutical laboratories, medical device companies, Mexican government health institutions, international organizations, and civil society groups, helping them navigate market access, reimbursement, and public health policy decisions. TIS operates through three primary business units — Market Access (split between pharma and medical devices), Health Systems, and Scientific Research and Dissemination — and maintains a dedicated RWE sub-brand called Sináptica that conducts observational studies, patient-reported outcomes research, database analysis, Delphi panels, and real-evidence-based economic models.

The firm's core technology is its consulting methodology and its Sináptica RWE platform rather than a packaged software product; revenue is generated through project-based professional services engagements priced per scope. TIS distributes its services directly to enterprise and government clients and supplements delivery through strategic alliances with regional consulting firms (Inteligencia Sanitaria, Cabildum, Zeed, Asterisco, Inbedu, Mellow, Espamedic) and sector institutions (FunSalud, ISPOR Mexico Chapter, Hormonia). The company employs 11-50 multidisciplinary professionals led by Founder/CEO Dr. Juan Gabriel Gay Molina (formerly of the Mexican Ministry of Health, OECD, and the London School of Hygiene and Tropical Medicine), and supports demand generation through the 'Puerta de Acceso' podcast on Spotify, a corporate blog, and LinkedIn/Facebook thought-leadership content.

The business model is that of a boutique professional services firm: revenue comes from discrete consulting projects (cost-effectiveness and budget-impact analyses, HTA dossiers, market access strategy, policy diagnostics, systematic reviews), and there is no subscription or recurring software revenue disclosed. With 15+ years of operating history, a Mexico-anchored client base with stated Latin American reach, and a founder-led ownership structure with no external institutional investors, TIS functions as a stable, specialist advisory practice rather than a venture-backed or high-growth technology company.

Name

Tecnología e Información para la Salud

Legal name

Tecnología e Informática para la Salud S.A. de C.V.

Website

https://tisalud.com.mx

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

TIS is a Mexico City-based healthcare consulting firm that provides health economics, pharmacoeconomics, health technology assessment, market access, and real-world evidence services to pharmaceutical, medical device, government, and international organization clients across Mexico and Latin America.

Ownership category

akta.pro rank

Product category

Healthcare Consulting

NAICS

Professional, Scientific, and Technical Services (541), Scientific Research and Development Services (5417)

SIC

Services-Management Consulting Services (8742), Services-Health Services (8000)

akta.pro primary industry

Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN)

akta.pro secondary industries

Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG), DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM), Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

Keywords

• Health economics consulting
• Pharmacoeconomics services
• Market access consulting
• Real-world evidence
• Public health policy

Headquarters

HQ city

Mexico City

HQ country

Mexico

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Consulting Services: Professional consulting services in pharmacoeconomics, market access, health technology assessment, economic evaluation, and public health policy analysis. Revenue generated through project-based consulting engagements with healthcare companies, government institutions, and international organizations.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

TIS is a healthcare-focused consulting firm that advises pharmaceutical manufacturers, medical device companies, government health institutions, international organizations, and civil society groups on pharmacoeconomics, market access strategies, health systems analysis, and real-world evidence generation. Its work spans cost-effectiveness and cost-utility evaluations, budgetary impact studies, micro-costing, economic dossiers, public policy diagnostics, program impact evaluations, and scientific dissemination, organized through three business units (Market Access, Health Systems, and Scientific Research and Dissemination) alongside a dedicated Sináptica sub-brand for real-world evidence.

Product overview

TIS (Tecnología e Información para la Salud) is a consulting firm with over 15 years of experience in pharmacoeconomics, health technology access, real-world evidence, and public health policy analysis. The company operates as a unified consulting offering organized into three main business units: Market Access, Health Systems, and Scientific Research and Dissemination. TIS also operates Sináptica as a sub-brand specializing in real-world evidence generation. Additional content platforms include Puerta de Acceso podcast.

Differentiator

Problem solved

Functional benefit

Brands

• Sináptica: A TIS-associated brand that focuses on capturing real-world evidence to generate useful and contextualized evidence. Services include retrospective and prospective observational studies, clinical record reviews, patient pathway analysis, database analysis, patient-reported outcomes (PROs), economic models based on real evidence, and Delphi/expert panels.

Products and services

• Market Access Services Consulting services for pharmaceutical and medical device companies that include cost-effectiveness and cost-utility evaluations, budgetary impact studies, micro-costing, dossier development, value-added messaging, support for inclusion in basic tables and forms, and strategic analysis for public and private sector access across Mexico and Latin America.
• Health Systems Services Studies and analyses for government and multilateral clients covering policy environment diagnostics, social and health program impact evaluation, disease burden studies, access maps and key players, regulatory analysis, best practices identification, performance and outcomes assessment, and economic evaluation.
• Scientific Research and Dissemination Services Technical scientific products and advisory including systematic reviews and meta-analyses, statistical analysis of health databases, scientific article publication, and editing, design and distribution of technical materials for healthcare and research institutions.
• Sináptica Real-World Evidence Service A TIS sub-brand delivering real-world evidence services including retrospective and prospective observational studies, clinical record reviews, patient pathway analysis, clinical and administrative database analysis, patient-reported outcomes (PROs), economic models based on real evidence, and Delphi and expert panels.
• Puerta de Acceso Podcast A podcast space offering current topics, news, interviews, and issues related to health, public policy, and pharmacoeconomics, featuring the multidisciplinary TIS team and guest experts and available on Spotify.

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Twelve partnerships are on record, tiered core, supporting and minor.

• Inteligencia SanitariacoreStrategic or Co-development PartnerHealthcare intelligence consulting firm partner that combines strengths with TIS to expand reach in Latin America and offer more comprehensive specialized solutions in health economics and policy analysis.
• CabildumsupportingStrategic or Co-development PartnerConsulting firm partner contributing complementary capabilities to enhance TIS service offerings in health sector consulting.
• ZeedsupportingStrategic or Co-development PartnerConsulting firm partner that combines expertise with TIS to provide more specialized solutions to clients.
• AsteriscosupportingStrategic or Co-development PartnerConsulting firm partner expanding TIS capabilities through combined strengths in health sector expertise.
• InbedusupportingStrategic or Co-development PartnerEducation-focused consulting partner (affiliated with Edufarm) that works with TIS to enhance knowledge transfer and technical capabilities.
• Inet MexicosupportingStrategic or Co-development PartnerTechnology consulting partner that complements TIS capabilities in providing comprehensive health sector solutions.
• MellowsupportingStrategic or Co-development PartnerConsulting firm partner contributing to TIS collaborative efforts in Latin American health consulting.
• EspamedicsupportingStrategic or Co-development PartnerHealthcare-focused consulting partner that works with TIS to deliver specialized health sector advisory services.
• XR Marketing & DesignminorImplementation/ SI/ Consulting PartnerMarketing and design services partner responsible for TIS website design and branding, as credited in footer.
• FunSalud (Fundación Mexicana para la Salud)coreStrategic or Co-development PartnerMajor health foundation in Mexico working with TIS to expand impact on community health and promote benefits for the population through collaborative initiatives.
• ISPOR Mexico ChaptercoreStrategic or Co-development PartnerInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR) Mexico Chapter partnership for advancing pharmacoeconomics and health economics in Mexico and Latin America.
• HormoniasupportingStrategic or Co-development PartnerHealth and social welfare organization partner that collaborates with TIS to expand community impact and promote population health benefits.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Regional players

• Asterisco: Mexico-based consulting firm partner of TIS. Comparable as a regional peer offering health-sector advisory services in Mexico and Latin America.
• Cabildum: Mexico-based consulting firm partner of TIS. Comparable as a regional peer providing complementary health sector consulting capabilities in the same geography.
• Espamedic: Mexico-based healthcare-focused consulting partner of TIS. Comparable as a regional consulting peer focused on health sector advisory work in the Mexican market.

Broad incumbents

• Precision Medicine Group: Specialized life sciences services firm offering evidence generation, market access, and HEOR services. Comparable to TIS in serving the same pharma market access and evidence generation buyer.
• IQVIA: Diversified life sciences services giant with a substantial HTA, real-world evidence, and market access practice. Directly comparable to TIS's evidence-generation and market access work, especially with global pharma clients.
• Trinity Life Sciences: Life sciences strategy and evidence consultancy with strong HTA, market access, and RWE capabilities. Comparable service mix to TIS for pharma and medtech clients.
• Evidera (part of Thermo Fisher Scientific / PPD): Global HEOR, HTA, and real-world evidence consultancy. Comparable because it offers the same pharmacoeconomic, market access, and RWE services that TIS delivers, but at much larger scale and with a global footprint.
• Charles River Associates (CRA) — Life Sciences Practice: Global management consultancy with a dedicated life sciences practice covering HTA, market access, and HEOR strategy. Overlaps with TIS's market access and health economics engagements with pharma and medical device clients.

Others

• ISPOR (International Society for Pharmacoeconomics and Outcomes Research): Global professional society in HEOR with an active Mexico Chapter that partners with TIS. Relevant as an ecosystem enabler that shapes demand for the same HTA and pharmacoeconomic services TIS sells.

Direct peers

• Inteligencia Sanitaria: Mexico-based health intelligence consulting firm listed as a core strategic partner of TIS. Closest direct peer, offering overlapping health economics and policy advisory services in the same geography.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/100071160739738
• LinkedInlinkedin.com/company/t.i.salud
• Xx.com/TISaludmx

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tecnología e Información para la Salud